| Celia Rodriguez, MD | |
|
1741 Sycamore Ave, Kingman, AZ 86409-0927 | |
| (928) 757-8111 | |
| (928) 757-3256 |
| Full Name | Celia Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1741 Sycamore Ave, Kingman, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780752816 | NPI | - | NPPES |
| 576118 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 28932 (Arizona) | Primary |
| Entity Name | West Michigan Community Mental Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275646309 PECOS PAC ID: 8426046855 Enrollment ID: O20040504001447 |
News Archive
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
New University of Georgia research, published this week in the early online edition of the journal Proceedings of the National Academy of Sciences, has found that blocking the action of an enzyme called GnT-V significantly delays the onset and spread of tumors in mice with cancer very similar to many cases of human breast cancer.
Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, in the largest study undertaken to date.
IPSEN, a global biopharmaceutical company represented by Claude Bertrand, Executive Vice President, R&D and Chief Scientific Officer, and Institut de cancérologie Gustave Roussy, a leading international cancer center represented by Professor Alexander Eggermont, General Director, today announced the signature of a partnership in the area of medical oncology to leverage the combined expertises of their respective R&D teams.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Celia Rodriguez, MD 1741 Sycamore Ave, Kingman, AZ 86409-0927 Ph: (928) 757-8111 | Celia Rodriguez, MD 1741 Sycamore Ave, Kingman, AZ 86409-0927 Ph: (928) 757-8111 |
News Archive
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.
New University of Georgia research, published this week in the early online edition of the journal Proceedings of the National Academy of Sciences, has found that blocking the action of an enzyme called GnT-V significantly delays the onset and spread of tumors in mice with cancer very similar to many cases of human breast cancer.
Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, in the largest study undertaken to date.
IPSEN, a global biopharmaceutical company represented by Claude Bertrand, Executive Vice President, R&D and Chief Scientific Officer, and Institut de cancérologie Gustave Roussy, a leading international cancer center represented by Professor Alexander Eggermont, General Director, today announced the signature of a partnership in the area of medical oncology to leverage the combined expertises of their respective R&D teams.
› Verified 9 days ago
Arif Husain, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3505 Western Ave, Kingman, AZ 86409 Phone: 928-757-8111 Fax: 928-757-1199 | |
Mr. Elias Omar Ruiloba, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2002 N Stockton Hill Rd, #104, Kingman, AZ 86401 Phone: 928-718-4800 Fax: 928-757-3256 | |
Dr. Sirpa A Tavakoli, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1743 Sycamore Ave, Kingman, AZ 86409 Phone: 928-757-8111 | |
Laurence David Seltzer, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 915 Airway Ave Ste A, Kingman, AZ 86409 Phone: 928-718-4800 | |
Dr. Laurence Schiff, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3931 Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-681-2121 Fax: 928-681-2000 | |
Dr. Ernest Lavere Harman Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5036 Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-377-1615 Fax: 928-692-1888 |